MaRS Impact Health addresses the most important issues facing the health innovation community

An intimate roundtable for philanthropic leaders delving into opportunities in women’s health innovation, and how Canada’s philanthropic community can support transformative women’s health ventures with the potential for large-scale impact.

Join attendees for pre-conference networking and coffee while visiting the MaRS Impact Health expo.

What to look forward to on day two of MaRS Impact Health, followed by a short pulse check on innovation in the device and digital health sectors.

Brittany Barreto will explore the landscape of women’s health innovation, drawing on her unique background as a scientist and entrepreneur. With a focus on technology and investment, she’ll discuss practical strategies for advancing FemTech and transforming healthcare for women globally.

For too long, male physiology has informed health care for women. It’s time that women’s health be viewed as more than a niche market and not just through the narrow lens of reproductive health. This panel delves into ongoing gaps and why it’s critical that investors prioritize women’s health innovation.

Bayer and Google Cloud announce a collaboration focused on development of artificial intelligence solutions to support radiologists.

Imaging data accounts for about 90 percent of all healthcare data. This makes it one of the most important sources of clinical evidence for diagnosis and managing patient conditions. How might AI solutions support the handling, analysis and interpretation of medical imaging data? What do these tools look like when applied in clinical practice? How can Canada’s health systems adopt AI and deploy it in a way that helps radiologists and other clinicians who are under pressure and under-resourced? This panel will explore advances in novel AI-powered medical imaging technologies and pathways towards market adoption for impactful outcomes.

Medical imaging is the spark to nearly every patient journey, yet manual and legacy image sharing systems deemphasize patient access to their own data, generating unnecessary costs, and delaying patient care. Hear from PocketHealth CEO Rishi Nayyar about evolving the way medical images are shared, while leveraging AI to personalize the patient’s care journey with access, control, and a deeper understanding of their health records.

AI-driven healthcare solutions have been in the works for years, but the direct patient impacts are still limited. In this panel, we hear how healthcare experts are navigating the challenges of implementing and using AI in clinical practice with insights that can be applied in any field.

Explore AI-powered apps that assist radiologists, reduce burnout and support more efficient diagnoses. This workshop is presented by Bayer.

Join the Ontario Brain Institute’s Centre for Analytics for a session showcasing pioneering neurotechnology ventures and research, culminating in a panel discussion delving into data in the realm of precision neuroscience.

As of now, there are no commercially-available devices that measure blood glucose non-invasively. Learn how Synex Medical is attempting to solve for this.

People living with disabilities often can’t get the assistive devices they need, and startups in this space face numerous barriers when commercializing these solutions. This panel features several experts navigating and supporting ventures as they tackle these scaling challenges.

A founder’s mental well-being is a critical determinant of startup success. Limited access to mental health support is an added challenge for founders and their teams. This session will discuss the results of a recent survey conducted by MaRS and District 3.

Fewer than one-third of companies make it past the first five years and if they do, it’s even harder to scale. For healthtech ventures, securing investment often means proving a product or application has meaningful clinical impact. Clinical validation implies that startups can test their solutions in a real healthcare setting, something that isn’t currently possible in Canada. This panel will explore opportunities and resources for the health system to better support healthtech ventures in Canada.

Hear from global medtech market strategics Boston Scientific and Stryker on their Canadian footprints, areas of focus and approach to partnering. Moderated by an executive from AdvaMed, the world’s largest trade organization representing medical technology (device, diagnostic, imaging and digital health technologies companies) and the organizer of The MedTech Conference.

That’s a wrap! Join us for a closing reception as we celebrate MaRS Impact Health 2024 and its founders, entrepreneurs, partners and speakers.